Analyst Consensus ?
ConsensusBuy49 ratings
Bullish3265.3%
Neutral1632.7%
Bearish12.0%
FN2 Earnings Intelligence
Biogen Inc. analyst ratings
Biogen Inc. (BIIB) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$247.65Current
$157Low
$246.98Average
$405High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| B of A Securities | Neutral | Neutral | Maintain | Oct 22, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 21, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 20, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Oct 12, 2026 |
| UBS | Buy | Buy | Maintain | Oct 9, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 8, 2026 |
| HSBC | Reduce | Reduce | Maintain | Sep 10, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Sep 3, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Aug 13, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Aug 4, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Wedbush | Neutral | Neutral | Maintain | Jul 30, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| HC Wainwright & Co. | Buy | Buy | Maintain | Jul 30, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Jul 30, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 21, 2026 |
| Truist Securities | Buy | Hold | Upgrade | Jul 13, 2026 |
| Needham | Buy | Buy | Maintain | Jun 29, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 1, 2026 |
| Freedom Broker | Hold | Hold | Maintain | Feb 23, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Feb 9, 2026 |
| Stifel | Buy | Hold | Upgrade | Nov 6, 2025 |
| Bernstein | Market Perform | Market Perform | Maintain | Nov 3, 2025 |
| Baird | Outperform | Outperform | Maintain | May 2, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 23, 2025 |
| Argus Research | Hold | Buy | Downgrade | Apr 4, 2025 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Feb 13, 2025 |
| Jefferies | Hold | Buy | Downgrade | Dec 9, 2024 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Sep 9, 2024 |
| Raymond James | Outperform | Market Perform | Upgrade | Dec 7, 2023 |
| Atlantic Equities | Neutral | Neutral | Maintain | Aug 8, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 16, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Oct 26, 2022 |
| William Blair | Outperform | Market Perform | Upgrade | Jun 8, 2021 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 4, 2021 |
| DZ Bank | Buy | Hold | Upgrade | Nov 10, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 23, 2020 |
| Nomura | Buy | Buy | Maintain | Feb 7, 2020 |
| Standpoint Research | Hold | Buy | Downgrade | Nov 1, 2019 |
| Piper Jaffray | Neutral | Overweight | Downgrade | Jun 28, 2019 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Feb 21, 2019 |
| Argus | Hold | Buy | Downgrade | Feb 16, 2018 |
| H.C. Wainwright | Buy | Buy | Maintain | Jan 26, 2018 |
| Bank of America | Buy | Buy | Maintain | Oct 18, 2017 |
| Leerink Swann | Market Perform | Outperform | Downgrade | Mar 16, 2017 |
| PiperJaffray | Overweight | Neutral | Upgrade | Nov 7, 2016 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 24, 2014 |
| FBR Capital | Outperform | Outperform | Maintain | Oct 2, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $247.65. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BMO Capital | Analyst unavailable | $220 | $232.95 | -11.2% | Oct 12, 2026 |
| UBS | Analyst unavailable | $270 | $223.25 | +9.0% | Oct 9, 2026 |
| RBC Capital | Analyst unavailable | $256 | $219.91 | +3.4% | Oct 8, 2026 |
| Stifel Nicolaus | Paul Matteis | $242 | $214.77 | -2.3% | Sep 10, 2026 |
| HSBC | Analyst unavailable | $175 | $210.73 | -29.3% | Sep 10, 2026 |
| Piper Sandler | Analyst unavailable | $245 | $222.67 | -1.1% | Sep 3, 2026 |
| RBC Capital | Analyst unavailable | $260 | $218.12 | +5.0% | Aug 25, 2026 |
| Wolfe Research | Analyst unavailable | $300 | $208.87 | +21.1% | Aug 13, 2026 |
| Morgan Stanley | Terence Flynn | $231 | $206.5 | -6.7% | Jul 30, 2026 |
| H.C. Wainwright | Analyst unavailable | $251 | $205.74 | +1.4% | Jul 30, 2026 |
| RBC Capital | Analyst unavailable | $240 | $204.1 | -3.1% | Jul 30, 2026 |
| UBS | Analyst unavailable | $240 | $204.62 | -3.1% | Jul 30, 2026 |
| Canaccord Genuity | Analyst unavailable | $248 | $209.23 | +0.1% | Jul 30, 2026 |
| Oppenheimer | Jay Olson | $300 | $209.23 | +21.1% | Jul 29, 2026 |
| Guggenheim | Yatin Suneja | $280 | $203.02 | +13.1% | Jul 21, 2026 |
| Wedbush | Analyst unavailable | $201 | $202.04 | -18.8% | Jul 13, 2026 |
| Truist Financial | Analyst unavailable | $235 | $199.15 | -5.1% | Jul 13, 2026 |
| Morgan Stanley | Terence Flynn | $222 | $205.7 | -10.4% | Jul 8, 2026 |
| RBC Capital | Analyst unavailable | $242 | $208.46 | -2.3% | Jul 7, 2026 |
| HSBC | Morten Herholdt | $157 | $213.26 | -36.6% | Jul 6, 2026 |
| Morgan Stanley | Analyst unavailable | $224 | $198.67 | -9.5% | Jun 18, 2026 |
| Mizuho Securities | Salim Syed | $221 | $200.05 | -10.8% | Jun 15, 2026 |
| Needham | Analyst unavailable | $255 | $195.34 | +3.0% | Jun 8, 2026 |
| RBC Capital | Brian Abrahams | $227 | $193.08 | -8.3% | May 27, 2026 |
| Piper Sandler | Analyst unavailable | $225 | $191.37 | -9.1% | May 15, 2026 |
| Morgan Stanley | Analyst unavailable | $206 | $188.76 | -16.8% | Apr 30, 2026 |
| RBC Capital | Brian Abrahams | $222 | $190.78 | -10.4% | Apr 30, 2026 |
| Wedbush | Analyst unavailable | $196 | $194.38 | -20.9% | Apr 30, 2026 |
| Guggenheim | Analyst unavailable | $260 | $194.38 | +5.0% | Apr 30, 2026 |
| Wells Fargo | Mohit Bansal | $250 | $177.35 | +0.9% | Apr 20, 2026 |
| Piper Sandler | Analyst unavailable | $214 | $176.36 | -13.6% | Apr 14, 2026 |
| Morgan Stanley | Analyst unavailable | $200 | $173.48 | -19.2% | Apr 10, 2026 |
| Barclays | Emily Field | $185 | $192.08 | -25.3% | Feb 19, 2026 |
| Mizuho Securities | Analyst unavailable | $236 | $188.99 | -4.7% | Feb 11, 2026 |
| Wedbush | Laura Chico | $187 | $192.72 | -24.5% | Feb 10, 2026 |
| Wolfe Research | Analyst unavailable | $231 | $196 | -6.7% | Feb 9, 2026 |
| RBC Capital | Analyst unavailable | $233 | $195.93 | -5.9% | Feb 9, 2026 |
| Wolfe Research | Analyst unavailable | $215 | $195.45 | -13.2% | Feb 9, 2026 |
| Truist Financial | Danielle Brill | $193 | $201.18 | -22.1% | Feb 9, 2026 |
| Canaccord Genuity | Analyst unavailable | $230 | $201.18 | -7.1% | Feb 9, 2026 |
| Piper Sandler | Analyst unavailable | $177 | $201.18 | -28.5% | Feb 9, 2026 |
| Guggenheim | Yatin Suneja | $246 | $201.18 | -0.7% | Feb 9, 2026 |
| Tudor Pickering | William Pickering | $201 | $201.18 | -18.8% | Feb 9, 2026 |
| H.C. Wainwright | Andrew Fein | $228 | $201.18 | -7.9% | Feb 9, 2026 |
| Wells Fargo | Analyst unavailable | $200 | $201.18 | -19.2% | Feb 8, 2026 |
| Morgan Stanley | Terence Flynn | $190 | $201.18 | -23.3% | Feb 8, 2026 |
| BMO Capital | Evan Seigerman | $196 | $201.18 | -20.9% | Feb 6, 2026 |
| Bernstein | Analyst unavailable | $191 | $179.09 | -22.9% | Feb 3, 2026 |
| Oppenheimer | Jay Olson | $225 | $176.18 | -9.1% | Jan 30, 2026 |
| Truist Financial | Analyst unavailable | $190 | $186.19 | -23.3% | Jan 8, 2026 |
| Goldman Sachs | Salveen Richter | $225 | $186.91 | -9.1% | Jan 8, 2026 |
| UBS | Analyst unavailable | $185 | $182.61 | -25.3% | Jan 6, 2026 |
| Morgan Stanley | Terence Flynn | $156 | $173.9 | -37.0% | Dec 12, 2025 |
| HSBC | Analyst unavailable | $143 | $175.8 | -42.3% | Dec 10, 2025 |
| Piper Sandler | Analyst unavailable | $157 | $168.18 | -36.6% | Nov 21, 2025 |
| Tudor Pickering | William Pickering | $157 | $153.64 | -36.6% | Nov 3, 2025 |
| Bernstein | Analyst unavailable | $157 | $154.27 | -36.6% | Nov 3, 2025 |
| Robert W. Baird | Analyst unavailable | $250 | $151.6 | +0.9% | Oct 31, 2025 |
| Morgan Stanley | Analyst unavailable | $149 | $150 | -39.8% | Oct 10, 2025 |
| Jefferies | Andrew Tsai | $190 | $137.67 | -23.3% | Sep 25, 2025 |
| RBC Capital | Brian Abrahams | $213 | $127.31 | -14.0% | Jun 25, 2025 |
| H.C. Wainwright | Andrew Fein | $187 | $122.41 | -24.5% | May 5, 2025 |
| Oppenheimer | Jay Olson | $205 | $123.53 | -17.2% | May 2, 2025 |
| HSBC | Analyst unavailable | $118 | $119.12 | -52.4% | Apr 28, 2025 |
| Canaccord Genuity | Sumant Kulkarni | $265 | $138.06 | +7.0% | Feb 13, 2025 |
| Citigroup | Geoff Meacham | $160 | $133.43 | -35.4% | Feb 12, 2025 |
| Jefferies | Michael Yee | $180 | $157.78 | -27.3% | Dec 9, 2024 |
| Robert W. Baird | Brian Skorney | $300 | $162.83 | +21.1% | Nov 15, 2024 |
| Oppenheimer | Jay Olson | $255 | $181.18 | +3.0% | Oct 31, 2024 |
| Morgan Stanley | Terence Flynn | $204 | $181.18 | -17.6% | Oct 31, 2024 |
| Raymond James | Christopher Raymond | $315 | $181.18 | +27.2% | Oct 30, 2024 |
| Goldman Sachs | Salveen Richter | $290 | $181.18 | +17.1% | Oct 30, 2024 |
| BMO Capital | Evan Seigerman | $230 | $188.16 | -7.1% | Oct 17, 2024 |
| UBS | Ashwani Verma | $202 | $188.74 | -18.4% | Oct 3, 2024 |
| Wedbush | Laura Chico | $205 | $199.36 | -17.2% | Sep 23, 2024 |
| Robert W. Baird | Brian Skorney | $294 | $212.7 | +18.7% | Jul 29, 2024 |
| Goldman Sachs | Salveen Richter | $342 | $211.17 | +38.1% | Jul 26, 2024 |
| Piper Sandler | Christopher Raymond | $307 | $211.17 | +24.0% | Jul 26, 2024 |
| RBC Capital | Brian Abrahams | $282 | $214.16 | +13.9% | Jul 26, 2024 |
| Piper Sandler | Christopher Raymond | $313 | $236.8 | +26.4% | Jul 12, 2024 |
| Morgan Stanley | Terence Flynn | $311 | $232.75 | +25.6% | Jul 11, 2024 |
| Scotiabank | George Farmer | $275 | $230.28 | +11.0% | Jun 12, 2024 |
| BMO Capital | Evan David Seigerman | $260 | $220 | +5.0% | May 23, 2024 |
| Stifel Nicolaus | Paul Matteis | $275 | $225.21 | +11.0% | May 22, 2024 |
| Raymond James | Christopher Raymond | $335 | $225.21 | +35.3% | May 22, 2024 |
| Morgan Stanley | Matthew Harrison | $331 | $224.48 | +33.7% | May 22, 2024 |
| Wedbush | Laura Chico | $215 | $204.65 | -13.2% | Apr 25, 2024 |
| H.C. Wainwright | Andrew Fein | $300 | $201.99 | +21.1% | Apr 25, 2024 |
| RBC Capital | Brian Abrahams | $317 | $201.99 | +28.0% | Apr 25, 2024 |
| Oppenheimer | Jay Olson | $270 | $190.52 | +9.0% | Apr 19, 2024 |
| Barclays | Carter Gould | $215 | $206.38 | -13.2% | Apr 3, 2024 |
| Wedbush | Laura Chico | $269 | $271.23 | +8.6% | Aug 7, 2023 |
| Guggenheim | Yatin Suneja | $350 | $311.11 | +41.3% | May 1, 2023 |
| Atlantic Equities | Analyst unavailable | $295 | $305.17 | +19.1% | Dec 1, 2022 |
| Jefferies | Analyst unavailable | $350 | $308.44 | +41.3% | Nov 30, 2022 |
| Wedbush | Analyst unavailable | $247 | $302.84 | -0.3% | Nov 30, 2022 |
| Barclays | Analyst unavailable | $313 | $291.41 | +26.4% | Nov 30, 2022 |
| Truist Financial | Analyst unavailable | $350 | $301.86 | +41.3% | Nov 15, 2022 |
| Guggenheim | Analyst unavailable | $270 | $286.86 | +9.0% | Nov 11, 2022 |
| J.P. Morgan | Analyst unavailable | $275 | $264.28 | +11.0% | Sep 30, 2022 |
| Atlantic Equities | Steve Chesney | $200 | $271.16 | -19.2% | Sep 28, 2022 |
| Wedbush | Analyst unavailable | $217 | $277.58 | -12.4% | Sep 28, 2022 |
| Wells Fargo | Analyst unavailable | $350 | $270.28 | +41.3% | Sep 28, 2022 |
| RBC Capital | Analyst unavailable | $321 | $275.88 | +29.6% | Sep 28, 2022 |
| Piper Sandler | Analyst unavailable | $280 | $197.79 | +13.1% | Sep 28, 2022 |
| BMO Capital | Evan David Seigerman | $360 | $197.79 | +45.4% | Sep 28, 2022 |
| Needham | Ami Fadia | $250 | $197.79 | +0.9% | Sep 28, 2022 |
| Robert W. Baird | Brian Skorney | $340 | $197.79 | +37.3% | Sep 28, 2022 |
| Truist Financial | Analyst unavailable | $265 | $195.92 | +7.0% | Sep 22, 2022 |
| Stifel Nicolaus | Analyst unavailable | $223 | $215.38 | -10.0% | Sep 12, 2022 |
| Cowen & Co. | Analyst unavailable | $270 | $214.1 | +9.0% | Jul 21, 2022 |
| Truist Financial | Analyst unavailable | $270 | $213.15 | +9.0% | Jul 21, 2022 |
| Barclays | Analyst unavailable | $200 | $212.95 | -19.2% | Jul 21, 2022 |
| Oppenheimer | Analyst unavailable | $230 | $216.68 | -7.1% | Jul 18, 2022 |
| Barclays | Analyst unavailable | $210 | $205.7 | -15.2% | May 4, 2022 |
| Leerink Partners | Analyst unavailable | $270 | $221.36 | +9.0% | Apr 21, 2022 |
| Wells Fargo | Mohit Bansal | $265 | $212.55 | +7.0% | Apr 18, 2022 |
| Barclays | Carter Gould | $219 | $212.55 | -11.6% | Apr 16, 2022 |
| Needham | Ami Fadia | $262 | $210.62 | +5.8% | Apr 11, 2022 |
| Wedbush | Laura Chico | $185 | $214.75 | -25.3% | Apr 9, 2022 |
| Jefferies | Michael Yee | $300 | $211.64 | +21.1% | Apr 7, 2022 |
| Robert W. Baird | Brian Skorney | $224 | $211.64 | -9.5% | Apr 7, 2022 |
| Piper Sandler | Christopher Raymond | $200 | $211.64 | -19.2% | Apr 7, 2022 |
| RBC Capital | Brian Abrahams | $244 | $207.61 | -1.5% | Apr 5, 2022 |
| Bank of America Securities | Geoff Meacham | $225 | $211.68 | -9.1% | Mar 28, 2022 |
| BMO Capital | Evan Seigerman | $238 | $197.36 | -3.9% | Mar 15, 2022 |
| Canaccord Genuity | Sumant Kulkarni | $285 | $211.01 | +15.1% | Feb 28, 2022 |
| Guggenheim | Yatin Suneja | $200 | $209.81 | -19.2% | Feb 22, 2022 |
| Truist Financial | Robyn Karnauskas | $320 | $214.55 | +29.2% | Feb 16, 2022 |
| Needham | Ami Fadia | $290 | $214.59 | +17.1% | Feb 13, 2022 |
| Mizuho Securities | Salim Syed | $207 | $221.3 | -16.4% | Feb 7, 2022 |
| Morgan Stanley | Matthew Harrison | $330 | $221.53 | +33.3% | Feb 4, 2022 |
| Barclays | Carter Gould | $235 | $221.53 | -5.1% | Feb 4, 2022 |
| Wolfe Research | Tim Anderson | $217 | $221.53 | -12.4% | Feb 4, 2022 |
| Wells Fargo | Mohit Bansal | $235 | $221.53 | -5.1% | Feb 4, 2022 |
| Cowen & Co. | Phil Nadeau | $285 | $221.53 | +15.1% | Feb 4, 2022 |
| J.P. Morgan | Cory Kasimov | $236 | $220.17 | -4.7% | Feb 3, 2022 |
| Needham | Ami Fadia | $292 | $225.21 | +17.9% | Jan 30, 2022 |
| Jefferies | Michael Yee | $325 | $239.3 | +31.2% | Jan 16, 2022 |
| Cantor Fitzgerald | Alethia Young | $209 | $225.34 | -15.6% | Jan 12, 2022 |
| Bernstein | Aaron Gal | $400 | $244.14 | +61.5% | Jan 3, 2022 |
| Goldman Sachs | Salveen Richter | $271 | $224.11 | +9.4% | Dec 6, 2021 |
| UBS | Colin Bristow | $405 | $266.57 | +63.5% | Oct 20, 2021 |
| Atlantic Equities | Steve Chesney | $415 | $395.37 | +67.6% | Jun 8, 2021 |
Track every rating change on BIIB the moment it posts. Free to start.
Start freeGet the BIIB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.